Key result
The WHO has established a global laboratory network to ensure appropriate processing of specimens from acute flaccid paralysis cases for viral isolation to support polio eradication.
The WHO global laboratory network plays a key role in polio eradication by ensuring appropriate processing of specimens for viral isolation.
Answers are grounded in this paper and cite their sources.
Bolsters AFP surveillance infrastructure; leaves open whether coverage suffices for eradication endpoints.
In 1988, the World Health Assembly resolved to eradicate poliomyelitis globally by 2000. Substantial progress toward achieving this goal has been reported from all countries where polio is endemic, and three regions of the World Health Organization (WHO) (American Region, European Region, and Western Pacific Region) appear to be free of indigenous wild poliovirus transmission. One key strategy for polio eradication is establishing sensitive surveillance systems for polio (through notification of acute flaccid paralysis [AFP] cases) and poliovirus. To ensure that specimens from AFP cases undergo appropriate processing for viral isolation, WHO has established a global laboratory network. This report describes the proficiency of the network and provides updates on structure, accreditation, performance, expanding activities, and future plans.
No takes yet. Share an insight, caveat, or question.
A 2000 study studied Poliomyelitis. Global laboratory network for poliomyelitis eradication was evaluated on Network proficiency, structure, accreditation, performance, expanding activities, and future plans. The WHO has established a global laboratory network to ensure appropriate processing of specimens from acute flaccid paralysis cases for viral isolation to support polio eradication.
Synapse has enriched 10 related papers. Consider them for comparative context: